In conclusion, acacetin hinders ovarian cancer progression and angiogenesis by suppressing VEGF expression via inhibition of the AKT/HIF-1 signaling pathway (Liu et al., 2011). The gene discussed is AKT1; the disease is ovarian carcinoma.